Site Map
Pages
- 148 million dollar bill for Medicare drug abuse ???
- A potential new weapon to stop our fat attacks called Qnexa (phentermine plus topiramate)
- Aetna to provide some low cost or free drugs to patients after a heart attack
- Afrezza
- Alzheimers
- Amturnide and three drugs in one for high blood pressure
- Arthritis
- Benefit to risk decisions, consideration of Qnexa and involving your doctor
- Berberine and Type II Diabetes
- Blood Clot
- Blood thinners for beginners
- Breakthrough at AHA-CETP inhibitor born and to be researched for cholesterol therapy
- Breast cancer and traztuzumab plus neratinib target drug therapy hope
- Breast implants associated with rare lymphoma
- Cancer and OHOP--FDA reorganizes drug division
- Celexa (citalopram) more than 40 mg risky for your heart
- Cholesterol puzzles: Apolipoprotein A1 and investigational anacetrapib
- Chronic Diseases
- Chronic Pain
- Colleagues and Hospital Partners
- Contact Us
- Contrave and long wait for a new weight loss drug is probably over
- Contrave may join weight loss weapons in December
- Could a PCSK9 inhibitor treat YOUR cholesterol soon?
- Cymbalta in chronic pain and possible combinations
- Daily Diet Soda Associated With 61 % higher risk of blood vessel (vascular) events
- Denosumab: One drug with two names that treats osteoporosis and delays cancer spread to bones
- Depression
- Diabetes dilemmas, a small dose for you (click here)
- Did you get your flu vaccination yet? How about today?
- Disclaimer
- Drug Interactions in the news and Zyvox (linezolid), methylene blue and a variety of psychiatric medicines
- Drug Shortages impact hospitals and patients
- DVT (Deep Vein Thrombosis)
- eBooks We've Written
- Eloquent efficacy for Eliquis in atrial fibrillation patients
- Essential Guide to Prescription Drugs
- Exciting new cholesterol treatment approach
- Expanded access and getting clincial trial medicines
- Exuberance in Chicago at the EMPHASIS HF results for heart failure patients
- FDA Fails or FDA Failed to be supported?
- FDA Findings...when drugs break bad
- FDA rejects another weight loss drug
- FDA requires label changes for Tumor Necrosis Factor blockers for Rheumatoid Arthritis and Crohn's based on infection risks
- FDA's new plan for opioid misuse
- FDA: Stop taking and throw away Fruta Planta
- Fish oil falters for Alzheimer's but fits for your heart
- FluMist Quadrivalent--four virus types in one spray--the benefit of no shot, but you can't be 50
- Four Loko, Joose, Core High Gravity (HG, orange), Lemon Lime Core Spiked no longer to be shipped
- Free counseling from CancerCare
- Freedom from pain? IOM has a blueprint for transformation
- From DSM 4 to 5: Will lower diagnostic thresholds lead to overmedication in Psychiatry
- Generic Lexapro (escitalopram) approved by the FDA
- Getting to the Heart of Cardiology
- Getting to the Heart of Cholesterol
- Getting to the Heart of Diabetes
- Getting to the Heart of New Drugs
- Getting to the Heart of Oncology (Cancer)
- Gintuit- the first cell-based FDA approval for mucogingival problems
- Got Pain?...Cymbalta may help
- Heart Attacks
- Heartburn medicines (Nexium to Prilosec and back) and serious diarrhea
- Herbal and natural medicine and cholesterol
- High Blood Pressure Attacks
- Hospital Consulting Services
- Important new treatment for the most common skin cancer (basal cell carcinoma) called Erivedge (vismodegib)
- Institute of Medicine may have missed the mark on Vitamin D and Calcium
- Insulin
- Intermezzo for those who wake up and can't get back to sleep
- Ipilimumab review delayed but shows promise for melanoma
- Is Contrave the new weight loss drug leader? An emergency ebola test and new pregnancy information in 2015
- Is the PRESENT study the key for a new vaccine for breast cancer?
- Join the Site
- Juvisync in sync for diabetes and cholesterol problems
- Kindle your interest in The Essential Guide to Prescription Drugs
- Knowing Livalo (pitavastatin)
- Knowing YOUR Family Cholesterol History
- Kombiglyze combination treatment for type 2 diabetes
- Large B-Vitamin doses and preventing Alzheimer's ???
- Lipitor going generic as atorvastatin
- Lipitor, Zocor, Pravachol and dose related side effects, and diabetes and what to do
- Long wait for weight loss at the FDA
- Lorcaserin (Lorqess) leaving the FDA launching pad?
- MADD Report to the nation on drunk driving
- Major Conferences We've Attended
- Medicine absorbed from the mouth--the latest in cancer pain
- Medicine Information Institute Copyright
- Membership - Here is a sneak peek
- My Blog
- N-3 Fatty Acids in low dose don't protect our hearts
- National Endometriosis month and NSAIDS to contraceptives
- National Patient Safety month and the Institute of Medicine
- New antibiotic fights even resistant bacteria in lungs and skin
- New blood thinner study in the news again
- New essential Guide to Prescription Drugs, Update on Alcohol communicates author concerns
- New FDA Approvals
- New monoclonal antibody to PCSK9 in Lipitor patients and possible 70% decrease in bad cholesterol
- New orphan drug (clobazam-Onfi) approved for Lennox-Gastaut seizures
- New Products We Trust
- No preservative in Zioptan (tafluprost) glaucoma drug from Merck may be a distinct advantage
- NSAIDS during pregnancy and miscarriage risk
- Nutrition Notes & Herbal Healing
- One pill and at least two benefits
- Onglyza (generic name: saxagliptin)
- Opana and other Extented Release or Long Acting opioids now have a REMS
- Osteoporosis
- Our Services
- Our Staff
- Poor Leg Circulation and Peripheral Artery Disease (PAD)
- Pradaxa Promise
- Pradaxa promise revealed in new atrial fibrillation (afib) guidelines
- Preorder -- Essential Guide 500 Brands You Should Know
- Putting the EMPHASIS on heart failure in Chicago
- Qnexa FDA weight loss pill NOT recommended for approval by committee-July 15, 2010
- Questions of the Month
- Remembering that alcohol (ethanol) IS a drug
- Request Dr. Rybacki for a Talk at Your Organization
- Riding a ROCKET for atrial fibrillation and stroke and embolism prevention
- Rybacki on the Radio
- Side Effects
- Site Map
- Small Doses
- Small doses of change from the American Heart Association meeting in Chicago
- SPEAK UP when in the hospital
- Stroke
- Stroke risk and hidden or undiagnosed diabetes
- Substantially equivalent reviews for tobacco products
- Taking health care into your own hands
- test
- Testing
- Thanks
- The fifth surfactant to be approved to treat Respiratory Distress Syndrome
- The first generic Crestor (rosuvastatin) approved by the FDA
- The first Helicobacter pylori breath test in children (BreathTek UBT)
- The Food and Drug Administration
- The new Guideline Advantage
- Time is brain--ask for quick treatment if you think you are having a stroke
- TJC and hospital quality for your family
- Two diseases treated with one pill (Juvisync-sitagliptin, simvastatin) ?
- Update on Weight
- Videos and Guest Expert Content
- Vitamin D dilemma, what dose should I take??
- Waiting for weight loss and Contrave
- Websites We Trust
- Weight Loss
- Weight worries and lead your family
- What is a Naturopathic Doctor?
- What on earth do those words mean?
- Where's the beef? FDA rejects Contrave combination of two FDA approved medicines
- Will lorcaserin (Lorquess) survive FDA scrutiny?
- Will YOU get the flu this year ???
- Xarelto
- Yervoy (ipilimumab) abstracts and valuable new information
- Yervoy (ipilimumab) and MDX 1106 (BMS-936558), a new investigational combination (NCT 01024231) in a previously abysmal metastatic melanoma battlefield
- Yervoy (ipilimumab) approved for melanoma by the FDA
- Yervoy (ipilimumab) melanoma immune-based therapy at FDA Feb 9, 2011
- Yervoy rejected by NICE, but what about the patients?
- Zelboraf (vemurafenib)--New hope in melanoma or combination therapy option?
Posts
- A CHANCE result for an older drug preventing strokes or will a US study make the POINT?
- A new dawn in cholesterol management or just a wind of change? PCSK9 and Lipitor patients
- American Heart scientific sessions and ALN-PCSsc, an RNAi Investigational Agent
- Be honest about your pain
- Belviq (lorcaserin) and Qsymia (Phentermine and topiramate) are now FDA approved, but when can YOU get them?
- C. Difficile, a diarrhea pathogen you should know
- Can a million hearts be saved?
- Can a side effect help you?
- Can canakinumab solve the inflammation flame?
- Can the weight be over June 27th for Lorquess?
- CLEAR wisdom and why is this being presented at the March 18th Late breaking Clinical Trial session in New Orleans?
- Counterfeit drugs and a new FDA warning on Avastin (bevacizumab) for cancer
- Credence - Invokana True Breakthrough
- Davy Jones of the Monkees dead at 66 from apparent heart attack
- Did you get your flu vaccination yet? How about today?
- Did you or a family member have a stroke or a heart attack? Could they be an undiagnosed diabetic too?
- Dr. Rybacki to be a guest on Conversations with Peter Solomon WIP, 94.1 FM April 8th 7:30 AM to 8 AM
- Dr. Rybacki to be on the Jordan Rich Show on WBZ in Boston talking about the Essential Guide to Prescription Drugs 2012
- Dr. Rybacki to guest on the Steve Cochran show KTRS-AM 550 AM April 10, 2012, Talking about the Essential Guide
- Drug newly approved for children in lymphoblastic leukemia
- Essential Guide to Prescription Drugs now available- PR Newswire
- Europe Medicines Committee takes a different view than US FDA committee and give go ahead for Xarelto in acute coronary syndrome
- European Medicines Agency (EMA) accepts new weight loss drug (Lorques-lorcaserin) for marketing review
- Exercise (physical activity guidelines) from HHS—did they hit the mark?
- FDA advises consumers not to buy or use "RigiRx Plus" because of undeclared drug ingredient
- FDA approved Stendra (vardenafil) for erectile dysfunction (ED) a few minutes ago
- FDA approves evolocumab (Repatha) for lowering cholesterol in the US
- FDA approves generic Plavix (clopidogrel) in a major after heart attack decision
- FDA safety communication on birth control pills that have drospirenone
- FDA says Aliskiren medicines & ACE inhibitors or Angiotensin Receptor Blockers risky in some kidney problems or diabetes
- FDA sends warning to Breathable Foods, makers of AeroShot caffeine inhaler
- FIRE and ICE and atrial fibrillation at the ACC meeting 2016
- First ever in-home, self administered HIV test (OraQuick) FDA approved
- First PCSK9 Inhibitor in the world is approved in Europe
- Flibanserin fine by FDA committee, with a risk plan recommendation
- Flibanserin folly or real female benefit for decreased sexual desire?
- Free Healthy Women Action Kit now available
- From DSM 4 to the new 5: Will Controversy lead to overmedication in Psychiatry??
- Guiding gathering for new cholesterol guidelines, what’s the threshold?
- Heart health/fewer heart attacks from Contrave, a weight loss drug?
- Helping your kidneys--the FDA pilots new technology for end-stage kidney disease
- Hey small brain
- Infant grape Tylenol voluntarily recalled in US by McNeil to prevent problems
- Is the PRESENT study a present for people with breast cancer?
- Join the fight against alcohol abuse
- Labeling changes for Vascepa? Who will now pay for the drug?
- LATITUDE falls off the map and CARIN careens off the road
- Live from the American College of Cardiology meeting in Chicago 2016
- Live opening session from the American College of Cardiology meeting in Chicago 2016
- Living better with cancer and the DEW approach from the American Cancer Society
- Looking beyond lipids, is there swelling evidence?
- Love that woman? Give her blueberries and strawberries 3 times a week
- Major label changes for statin cholesterol medicines (Crestor, Lipitor, Zocor, Mevacor, Livalo, Advicor, Pravachol, Simcor)
- Methaqualone (Quaaludes) in the news again
- More information on the newest cholesterol treatment-evolocumab- Rapatha
- Mysimba (Contrave-Naltexone plus bupropion in the EU) now approved for weight loss
- National Women's Health Week but where is the media ???
- New Biosimilar approval (biologic generic) may save billions in costs for rheumatoid arthritis patients
- New Essential Guide to Prescription Drugs, Upddate on Alcohol seeks to help prevent alcohol poisoning
- New study by Quest Diagnostics of almost 76,000 lab tests show more than 60% of patients misuse prescription drugs
- New test for Alzheimer's may give us an early wake up call
- News on The essential Guide to Prescription Drugs, Update on alcohol now available
- No preservatives in a new drug?--Zioptan (tafluprost) is a first preservative free prostaglandin analog drug for glaucoma
- Opioids, pain medicines and confusion over over doses
- Osphena (ospemifene) a new medicine for painful/difficult intercourse in women now FDA approved
- PDUFA day for evolocumab (Repatha) at the US FDA
- Priority FDA review granted for Xarelto (rivaroxaban) for use in preventing a second heart attack
- QNEXA (phentermine plus topiramate) weight loss drug recommended for approval by FDA advisory panel
- REDUCE-IT reduced MACE by 25%, does it validate Vascepa?
- Remember that alcohol (ethanaol) IS a drug
- Rybacki's recommendations: It's NOT just a little high blood pressure-take one small step today
- Rybacki's recommendations: Watch out for some heartburn medicines (Nexium to Prilosec and back) and diarrhea
- Shock at the Pharmacy Drive Up Window
- Shortage of ovarian cancer treatment (Doxil-doxorubicin hydrochloride liposome injection) & FDA action-is it enough?
- Sientra silicone breast implant approved by FDA conditional on after-approval studies for 10 years
- Some powerful Extended Release and Long Acting pain medicines get a risk plan from the FDA
- Thank you for all the emails and calls on the new Essential Guide to Prescription Drugs press release
- The Essential Guide to Prescription Drugs makes Amazon's Hot New Releases Best Pharmacology List
- The Essential Guide to Prescription Drugs, 12 Top Meds for 2012 is available on Amazon
- The Essential Guide to Prescription Drugs, 12 Top Meds for 2012 now available in full color printed and on Kindle
- The Weight is over--lorcaserin (Lorquess) gets the FDA nod
- Thinking about drug interactions and prescription drug bottles with Whitney Houston
- Tuesday morning at the American Heart in LA--Niacin/Niaspan and a closer look at AIM HIGH
- Twitter and medicine, is it a righteous mix?
- Viagra for heart failure?--RELAX and The American College of Cardiology meeting in San Francisco
- Weight loss medicines have been facing a tough FDA review will lorcaserin (Lorquess) survive?
- Weight. My weight and bad news from my doc. Join me in losing weight
- Why can’t my Mom get a PCSK9?
- Will 2018 AHA be an aha moment for cardiology?
- Will Andexxa answer crucial reversal questions?
- Will November 10th late breakers from the American Heart meeting validate Vascepa?
- Will the FDA approve QNEXA or opt for a one-year study and REMS ?
- Xarelto (rivaroxaban) on the agenda today for review for use in heart attacks (ACS)
- Xarelto gains a new CAD/PAD indication, what now?